Abnormal B cell signal transduction in systemic lupus erythematosus.
Abnormal B cell signal transduction in systemic lupus erythematosus.
复制标题
DOI:
10.1159/000066857
复制
发表时间:
2003
期刊:
影响因子:
--
通讯作者:
I. Khan;G. Tsokos;G. Kammer
中科院分区:
文献类型:
--
作者:
I. Khan;G. Tsokos;G. Kammer
B cells and B cell/T cell interactions play a key role in the pathophysiology of systemic lupus erythematosus (SLE). In contrast to the circulating T cell pool in SLE, B cells are not numerically decreased. Indeed, B cells have a heightened rate of proliferation and spontaneously secrete increased amounts of immunoglobulins (Ig), including autoantibodies (autoAbs) directed against self-nuclear, self-cytoplasmic, and self-plasma membrane autoantigens (autoAgs). Among this panoply of autoAbs, antinuclear autoAbs are directed against discrete nuclear autoAgs that result in characteristic immunofluorescent patterns by fluorescence microscopy [1–4]. A direct pathogenic role of these autoAbs has been demonstrated for at least some, such as anti-double-stranded DNA, anti-Ro and antiphospholipid autoAbs [5]. Besides secreting pathogenic autoAbs, recent evidence has provided pathophysiologically relevant insights into the role of B cells in shaping the immune repertoire, thereby pointing to new ways in which B cells may contribute to the immunopathogenesis of SLE. SLE B cells appear to have an intrinsic disorder that contributes to what has been generally termed ‘hyperactivity’. This term refers to diverse, abnormal functions, such as proliferation and augmented Ig synthesis, which culminate in hypergammaglobulinemia. This chapter will focus on the identified abnormalities of the SLE B cellsignaling pathway that contribute to the cell’s hyperactivity. Because knowledge of abnormal signaling in both human and murine SLE B cells is still very limited, our principal goal will be to compare physiologic B cell signaling mechanisms